SP1 and colorectal carcinoma: Taken together, these results indicated that Sp1 could abrogate the MIER3-induced inhibition of EMT in CRC, which further confirms that MIER3 suppresses CRC progression, at least in part, by directly reducing Sp1 and subsequently suppressing EMT.